These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20218007)

  • 1. Molecular weight distribution determination on heparin samples.
    Barlow GH
    Thromb Res; 1983 Aug; 31(3):513-8. PubMed ID: 20218007
    [No Abstract]   [Full Text] [Related]  

  • 2. USP compendial methods for analysis of heparin: chromatographic determination of molecular weight distributions for heparin sodium.
    Mulloy B; Heath A; Shriver Z; Jameison F; Al Hakim A; Morris TS; Szajek AY
    Anal Bioanal Chem; 2014 Aug; 406(20):4815-23. PubMed ID: 24958344
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of molecular weight of heparin by size exclusion chromatography with universal calibration.
    Guo X; Condra M; Kimura K; Berth G; Dautzenberg H; Dubin PL
    Anal Biochem; 2003 Jan; 312(1):33-9. PubMed ID: 12479832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatographic molecular weight measurements for heparin, its fragments and fractions, and other glycosaminoglycans.
    Mulloy B; Hogwood J
    Methods Mol Biol; 2015; 1229():105-18. PubMed ID: 25325948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determination of molecular weight distributions on heparin samples.
    Barlow GH
    Semin Thromb Hemost; 1985 Jan; 11(1):26-8. PubMed ID: 3975639
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array.
    Bertini S; Bisio A; Torri G; Bensi D; Terbojevich M
    Biomacromolecules; 2005; 6(1):168-73. PubMed ID: 15638517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and qualification of a size exclusion chromatography coupled with multiangle light scattering method for molecular weight determination of unfractionated heparin.
    Beirne J; Truchan H; Rao L
    Anal Bioanal Chem; 2011 Jan; 399(2):717-25. PubMed ID: 20838778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel method for the determination of average molecular weight of natural polymers based on 2D DOSY NMR and chemometrics: Example of heparin.
    Monakhova YB; Diehl BWK; Do TX; Schulze M; Witzleben S
    J Pharm Biomed Anal; 2018 Feb; 149():128-132. PubMed ID: 29112901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of unfractionated heparin: comparison of materials from the last 50 years.
    Mulloy B; Gray E; Barrowcliffe TW
    Thromb Haemost; 2000 Dec; 84(6):1052-6. PubMed ID: 11154113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A physical comparison of low molecular weight heparins prepared by different methods.
    Barlow GH; Petracek FJ
    Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):241-4. PubMed ID: 3764086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and structural characterization of large heparin-derived oligosaccharides.
    Pervin A; Gallo C; Jandik KA; Han XJ; Linhardt RJ
    Glycobiology; 1995 Feb; 5(1):83-95. PubMed ID: 7772871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.
    Edens RE; al-Hakim A; Weiler JM; Rethwisch DG; Fareed J; Linhardt RJ
    J Pharm Sci; 1992 Aug; 81(8):823-7. PubMed ID: 1328601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion-pairing reversed-phased chromatography/mass spectrometry of heparin.
    Henriksen J; Roepstorff P; Ringborg LH
    Carbohydr Res; 2006 Feb; 341(3):382-7. PubMed ID: 16360128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of anticoagulant activity of heparin].
    Dalmora SL; Assaf GS; Dalmora ME; Vaucher LC; Vaccari SF
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(2):59-62. PubMed ID: 1843369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-laboratory assessment of method accuracy (trueness and precision) by using validation standards.
    González AG; Herrador MA; Asuero AG
    Talanta; 2010 Oct; 82(5):1995-8. PubMed ID: 20875607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparins: process-related physico-chemical and compositional characteristics, fingerprints and impurities.
    Liverani L; Mascellani G; Spelta F
    Thromb Haemost; 2009 Nov; 102(5):846-53. PubMed ID: 19888518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a size exclusion chromatography method for determination of molecular masses and molecular mass distribution in low molecular weight heparin.
    Kristensen HI; Tromborg EM; Nielsen JR; Nielsen JI; Johansen KB; Ostergaard PB
    Thromb Res; 1991 Oct; 64(2):131-41. PubMed ID: 1667342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potency of heparin fractions obtained by gel filtration.
    Hall M; Ricketts CR; Michael SE
    J Pharm Pharmacol; 1969 Sep; 21(9):626-8. PubMed ID: 4390347
    [No Abstract]   [Full Text] [Related]  

  • 19. The issue with tissue--does size (of uncertainty in chemistry data) matter?
    Wernick B
    Integr Environ Assess Manag; 2012 Jan; 8(1):196-7. PubMed ID: 22184145
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluorophore-assisted carbohydrate electrophoresis for the determination of molecular mass of heparins and low-molecular-weight (LMW) heparins.
    Buzzega D; Maccari F; Volpi N
    Electrophoresis; 2008 Nov; 29(20):4192-202. PubMed ID: 18844319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.